{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:04:37Z","timestamp":1790327077533,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012557","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000}}],"reference-count":113,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012557.pub2","type":"journal-article","created":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T08:41:16Z","timestamp":1543394476000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Baclofen for alcohol use disorder"],"prefix":"10.1002","volume":"2018","author":[{"given":"Silvia","family":"Minozzi","sequence":"first","affiliation":[{"name":"Lazio Regional Health Service; Department of Epidemiology; Via Cristoforo Colombo, 112 Rome Italy 00154"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosella","family":"Saulle","sequence":"additional","affiliation":[{"name":"Lazio Regional Health Service; Department of Epidemiology; Via Cristoforo Colombo, 112 Rome Italy 00154"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"R\u00f6sner","sequence":"additional","affiliation":[{"name":"Forel Klinik; Islikonerstrasse 5 Ellikon an der Thur Switzerland 8548"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,11,26]]},"reference":[{"issue":"9603","key":"10.1002\/14651858.CD012557.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study","volume":"370","author":"Addolorato","year":"2007","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD012557.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.euroneuro.2016.10.006","article-title":"Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: a multicentre, randomised, double-blind controlled trial","volume":"26","author":"Beraha","year":"2017","journal-title":"European Neuropsychopharmacology"},{"issue":"11","key":"10.1002\/14651858.CD012557.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1111\/j.1530-0277.2010.01273.x","article-title":"Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial","volume":"34","author":"Garbutt","year":"2010","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"6","key":"10.1002\/14651858.CD012557.pub2-BIB0004|cit4","first-page":"178A","article-title":"Feasibility and tolerability of a combination of naltrexone and baclofen for alcohol dependence: a pilot study","volume":"34","author":"Garbutt","year":"2010","journal-title":"Alcoholism: Clinical and Experimental Research"},{"issue":"7","key":"10.1002\/14651858.CD012557.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/add.13787.","article-title":"The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial","volume":"112","author":"Hauser","year":"2017","journal-title":"Addiction"},{"issue":"2","key":"10.1002\/14651858.CD012557.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11055-016-0379-6","article-title":"Efficacy and safety of the use of baclofen in the treatment of alcohol dependent (a double-blind, randomized, placebo-controlled pilot study)","volume":"47","author":"Krupitskii","year":"2017","journal-title":"Neuroscience and Behavioral Physiology"},{"issue":"6","key":"10.1002\/14651858.CD012557.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.17116\/jnevro20151156153-62","article-title":"Double blind placebo controlled randomized pilot clinical trial of baclofen (Baclosan\u00ae) for alcohol dependence","volume":"115","author":"Krupitsky","year":"2015","journal-title":"Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova"},{"issue":"3","key":"10.1002\/14651858.CD012557.pub2-BIB0008|cit8","first-page":"265","article-title":"A double-blind, placebo-controlled randomized pilot study of the effects of baclofen on alcohol-tobacco co-use and alcohol cue-reactivity in alcoholic smokers","volume":"7","author":"Bollinger","year":"2014","journal-title":"Clinical and Translational Science"},{"issue":"1","key":"10.1002\/14651858.CD012557.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00213-014-3652-9","article-title":"A preliminary double-blind, placebo-controlled randomized study of baclofen effects in alcoholic smokers","volume":"232","author":"Leggio","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0010|cit10","first-page":"S69","article-title":"A study of comparative efficacy of baclofen vs acamprosate in reducing alcohol craving and abuse","volume":"52","author":"Mishra","year":"2010","journal-title":"Indian Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD012557.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1093\/alcalc\/agu062","article-title":"Baclofen for the treatment of alcohol dependence and possible role of comorbid anxiety","volume":"49","author":"Morley","year":"2014","journal-title":"Alcohol and Alcoholism"},{"issue":"8","key":"10.1002\/14651858.CD012557.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.euroneuro.2015.04.002","article-title":"High-dose baclofen for the treatment of alcohol dependence (BACLAD study): a randomized, placebo-controlled trial","volume":"25","author":"Muller","year":"2015","journal-title":"European Neuropsychopharmacology"},{"issue":"S1","key":"10.1002\/14651858.CD012557.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/S0924-9338(15)31243-8","article-title":"Individually titrated high-dose baclofen for the treatment of alcohol dependence (BACLAD study)-a randomized controlled trial","volume":"30","author":"Muller","year":"2015","journal-title":"European Psychiatry"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jsat.2014.11.007","article-title":"Baclofen as add-on to standard psychosocial treatment for alcohol dependence: a randomized, double-blind, placebo-controlled trial with 1 year follow-up","volume":"52","author":"Ponizovsky","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1002\/14651858.CD012557.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/alcalc\/agx030","article-title":"A randomized, placebo-controlled study of high-dose baclofen in alcohol-dependent patients-the ALPADIR Study","volume":"52","author":"Reynaud","year":"2017","journal-title":"Alcohol and Alcoholism"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/alcalc\/37.5.504","article-title":"Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomised controlled study","volume":"37","author":"Addolorato","year":"2002","journal-title":"Alcohol & Alcoholism"},{"issue":"10","key":"10.1002\/14651858.CD012557.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1097\/01.ALC.0000141640.48924.14","article-title":"Baclofen for alcohol dependence: a preliminary open-label study","volume":"28","author":"Flannery","year":"2004","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0018|cit18","first-page":"Poster #187","article-title":"Baclofen as a novel pharmacotherapy for alcohol dependence: preliminary findings from a human laboratory double-blind placebo-controlled randomized study [abstract]","volume":"36","author":"Leggio","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD012557.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.pbb.2012.11.013","article-title":"A human laboratory pilot study with baclofen in alcoholic individuals","volume":"103","author":"Leggio","year":"2013","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"3","key":"10.1002\/14651858.CD012557.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/alcalc\/agr017","article-title":"Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial","volume":"46","author":"Addolorato","year":"2011","journal-title":"Alcohol and Alcoholism (Oxford, Oxfordshire)"},{"issue":"4","key":"10.1002\/14651858.CD012557.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/alcalc\/agr061","article-title":"Response to Ameisen","volume":"46","author":"Addolorato","year":"2011","journal-title":"Alcohol and Alcoholism (Oxford, Oxfordshire)"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0022|cit22","unstructured":"CTRI\/2016\/01\/006525 Role of baclofen and topiramate in alcoholism ctri.nic.in\/Clinicaltrials\/pmaindet2.php?trialid=13646 2016"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0024|cit23","doi-asserted-by":"publisher","first-page":"S340","DOI":"10.1038\/npp.2014.281","article-title":"Baclofen as a pharmacotherapy for the treatment of concurrent alcohol and nicotine dependence: a double-blind, placebo-controlled, randomized trial","volume":"39","author":"Farokhnia","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD012557.pub2-BIB0023|cit24","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/npp.2015.29","article-title":"Corrigendum: T76. Baclofen as a pharmacotherapy for the treatment of concurrent alcohol and nicotine dependence: a double-blind, placebo-controlled, randomized trial (Neuropsychopharmacology (2014) 39 (S291-S472) DOI: 10.1038\/npp.2014.281)","volume":"40","author":"Farokhnia","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0025|cit25","first-page":"215a","article-title":"Baclofen for the treatment of alcohol drinkers (Bacloville)","volume":"38","author":"Jaury","year":"2014","journal-title":"Alcoholism: Clinical and Experimental Research"},{"issue":"2","key":"10.1002\/14651858.CD012557.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.cct.2013.08.002","article-title":"The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): study protocol for a randomised controlled trial","volume":"36","author":"Morley","year":"2013","journal-title":"Contemporary Clinical Trials"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/jgh.12006","article-title":"A dose-response effect of baclofen in reducing daily alcohol intake in alcohol-dependent subjects","volume":"27","author":"Sharma","year":"2012","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0028|cit28","unstructured":"CTRI\/2011\/11\/002154 Efficacy and safety of baclofen GRS for treatment of alcohol dependence, a 12 week study ctri.nic.in\/Clinicaltrials\/pmaindet2.php?trialid=3752"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0029|cit29","unstructured":"NCT01980706 Efficacy and safety of high dose baclofen for alcohol dependence clinicaltrials.gov\/show\/NCT01980706"},{"issue":"3","key":"10.1002\/14651858.CD012557.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/01.jcp.0000270079.84758.fe","article-title":"Baclofen suppresses alcohol intake and craving for alcohol in a schizophrenic alcohol-dependent patient: a case report","volume":"27","author":"Agabio","year":"2007","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD012557.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000347055","article-title":"Efficacy and tolerability of baclofen in substance use disorders: a systematic review","volume":"19","author":"Agabio","year":"2013","journal-title":"European Addiction Research"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fnins.2014.00140","article-title":"GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence","volume":"8","author":"Agabio","year":"2014","journal-title":"Frontiers in Neuroscience"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0033|cit33","first-page":"21","article-title":"Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project","volume":"420","author":"Alonso","year":"2004","journal-title":"Acta Psychiatrica Scandinavica. Supplementum"},{"issue":"3","key":"10.1002\/14651858.CD012557.pub2-BIB0034|cit34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005063.pub3","article-title":"Benzodiazepines for alcohol withdrawal","author":"Amato","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD012557.pub2-BIB0035|cit35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008537.pub2","article-title":"Efficacy and safety of pharmacological interventions for the treatment of the alcohol withdrawal syndrome","author":"Amato","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012557.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/alcalc\/agh130","article-title":"Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician","volume":"40","author":"Ameisen","year":"2005","journal-title":"Alcohol and Alcoholism (Oxford, Oxfordshire)"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0037|cit37","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1980"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0038|cit38","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1987"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0039|cit39","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0040|cit40","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"4","key":"10.1002\/14651858.CD012557.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/bcpt.12779","article-title":"Baclofen and alcohol-dependent patients: a real risk of severe self-poisoning","volume":"121","author":"Boels","year":"2017","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/CPAA.S32434","article-title":"Clinical effectiveness of baclofen for the treatment of alcohol dependence: a review","volume":"5","author":"Brennan","year":"2013","journal-title":"Clinical Pharmacology"},{"issue":"42","key":"10.1002\/14651858.CD012557.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/alcalc\/agl091","article-title":"Suppression of symptoms of alcohol dependence and craving using high-dose baclofen","volume":"2","author":"Bucknam","year":"2006","journal-title":"Alcohol and Alcoholism"},{"issue":"2","key":"10.1002\/14651858.CD012557.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/0269881111408463","article-title":"Substitution therapy for alcoholism: time for a reappraisal?","volume":"26","author":"Chick","year":"2012","journal-title":"Journal of Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD012557.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00213-003-1397-y","article-title":"Baclofen suppresses motivation to consume alcohol in rats","volume":"167","author":"Colombo","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0046|cit46","unstructured":"Veritas Health Innovation Covidence"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tips.2004.11.004","article-title":"Don't worry 'B' happy!: a role for GABA(B) receptors in anxiety and depression","volume":"26","author":"Cryan","year":"2005","journal-title":"Trends in Pharmacological Sciences"},{"issue":"11","key":"10.1002\/14651858.CD012557.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2165\/00002018-200427110-00004","article-title":"A benefit-risk assessment of baclofen in severe spinal spasticity","volume":"27","author":"Dario","year":"2004","journal-title":"Drug Safety"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0049|cit49","unstructured":"Deeks JJ Higgins JP Altman DG (editors) on behalf of the Cochrane Statistical Methods Group Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"6","key":"10.1002\/14651858.CD012557.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/01.ALC.0000171061.03686.BC","article-title":"Does effect size in naltrexone trials for alcohol dependence differ for single-site vs. multi-center studies?","volume":"29","author":"Feinn","year":"2005","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"11","key":"10.1002\/14651858.CD012557.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/j.1530-0277.2010.01273.x","article-title":"Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial","volume":"34","author":"Garbutt","year":"2010","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"2","key":"10.1002\/14651858.CD012557.pub2-BIB0052|cit52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005190.pub2","article-title":"Psychotropic analgesic nitrous oxide for alcoholic withdrawal states","author":"Gillman","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"19","key":"10.1002\/14651858.CD012557.pub2-BIB0053|cit53","first-page":"1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"GRADE Working Group","year":"2004","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0054|cit54","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"issue":"8","key":"10.1002\/14651858.CD012557.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","article-title":"Epidemiology of DSM-5 alcohol use disorder: results From the National Epidemiologic Survey on Alcohol and Related Conditions III","volume":"72","author":"Grant","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD012557.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1001\/jamapsychiatry.2017.2161","article-title":"Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001-2002 to 2012-2013: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"74","author":"Grant","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"7560","key":"10.1002\/14651858.CD012557.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012557.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1360-0443.2006.01584.x","article-title":"Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10)","volume":"101","author":"Hasin","year":"2006","journal-title":"Addiction"},{"issue":"8","key":"10.1002\/14651858.CD012557.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1176\/appi.ajp.2013.12060782","article-title":"DSM-5 criteria for substance use disorders: recommendations and rationale","volume":"170","author":"Hasin","year":"2013","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0062|cit62","unstructured":"Higgins JP Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0063|cit63","unstructured":"Higgins JP Altman DG Sterne JA (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ajp.2015.06.015","article-title":"High doses of baclofen as suicide attempt in patients with alcohol use disorders - a serious concern","volume":"17","author":"Holla","year":"2015","journal-title":"Asian Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD012557.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/ije\/dyu115","article-title":"Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies","volume":"43","author":"Hr\u00f3bjartsson","year":"2014","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/j.1530-0277.2011.01523.x","article-title":"The efficacy of disulfiram for the treatment of alcohol use disorder","volume":"35","author":"Jorgensen","year":"2011","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"1","key":"10.1002\/14651858.CD012557.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12903-016-0208-x","article-title":"Significance bias: an empirical evaluation of the oral health literature","volume":"16","author":"Kagereki","year":"2016","journal-title":"BMC Oral Health"},{"issue":"2","key":"10.1002\/14651858.CD012557.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0376-8716(93)90057-W","article-title":"Baclofen administration for the treatment of affective disorders in alcoholic patients","volume":"33","author":"Krupitsky","year":"1993","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0069|cit69","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/187152710790966614","article-title":"Effectiveness and safety of baclofen in the treatment of alcohol dependent patients","volume":"9","author":"Leggio","year":"2010","journal-title":"CNS & Neurological Disorders Drug Targets"},{"issue":"2","key":"10.1002\/14651858.CD012557.pub2-BIB0071|cit71","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006266.pub2","article-title":"Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses","author":"Leone","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD012557.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2515\/therapie\/2014038","article-title":"Efficacy of baclofen on abstinence and craving in alcohol-dependent patients: a meta-analysis of randomized controlled trials","volume":"69","author":"Lesouef","year":"2014","journal-title":"Therapie"},{"issue":"4","key":"10.1002\/14651858.CD012557.pub2-BIB0073|cit73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008502.pub4","article-title":"Baclofen for alcohol withdrawal","author":"Liu","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012557.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.alcohol.2005.08.003","article-title":"Baclofen-induced reduction of alcohol reinforcement in alcohol-preferring rats","volume":"36","author":"Maccioni","year":"2005","journal-title":"Alcohol"},{"issue":"7","key":"10.1002\/14651858.CD012557.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.alcohol.2009.09.030","article-title":"Role of the GABA(B) receptor in alcohol-seeking and drinking behavior","volume":"43","author":"Maccioni","year":"2009","journal-title":"Alcohol"},{"issue":"10","key":"10.1002\/14651858.CD012557.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1111\/j.1530-0277.2012.01782.x","article-title":"Comparison of the effect of the GABA\u0392 receptor agonist, baclofen, and the positive allosteric modulator of the GABAB receptor, GS39783, on alcohol self-administration in 3 different lines of alcohol-preferring rats","volume":"36","author":"Maccioni","year":"2012","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/978-3-642-28720-6_202","article-title":"Modeling relapse in animals","volume":"13","author":"Martin-Fardon","year":"2013","journal-title":"Current Topics in Behavioral Neurosciences"},{"issue":"3","key":"10.1002\/14651858.CD012557.pub2-BIB0078|cit78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006754.pub4","article-title":"Anticonvulsants for alcohol withdrawal","author":"Minozzi","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement","volume":"7","author":"Moher","journal-title":"PLoS Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012557.pub2-BIB0080|cit80","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003012.pub2","article-title":"Active placebos versus antidepressants for depression","author":"Moncrieff","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012557.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1360-0443.2006.01310.x","article-title":"Rates and predictors of relapse after natural and treated remission from alcohol use disorders","volume":"101","author":"Moos","year":"2006","journal-title":"Addiction"},{"issue":"4","key":"10.1002\/14651858.CD012557.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1055\/s-0042-103592","article-title":"Current findings and mechanisms of action of disulfiram in the treatment of alcohol dependence","volume":"49","author":"Mutschler","year":"2016","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1002\/14651858.CD012557.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1037\/1089-2680.2.2.175","article-title":"Confirmation bias: a ubiquitous phenomenon in many guises","volume":"2","author":"Nickerson","year":"1998","journal-title":"Review of General Psychology"},{"issue":"2","key":"10.1002\/14651858.CD012557.pub2-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008544.pub2","article-title":"Anticonvulsants for alcohol dependence","author":"Pani","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/JCP.0b013e31824929b2","article-title":"High-dose baclofen for treatment-resistant alcohol dependence","volume":"32","author":"Pastor","year":"2012","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD012557.pub2-BIB0086|cit86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010487","article-title":"Disulfiram for alcohol use disorder","author":"Pedersen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012557.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/15563650.2017.1284330","article-title":"Self-poisoning with baclofen in alcohol-dependent patients: national reports to French Poison Control Centers, 2008-2013","volume":"55","author":"Pelissier","year":"2017","journal-title":"Clinical Toxicology"},{"issue":"10","key":"10.1002\/14651858.CD012557.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1111\/ejn.12733","article-title":"GABA(B) modulation of dopamine release in the nucleus accumbens core","volume":"40","author":"Pitman","year":"2014","journal-title":"European Journal of Neuroscience"},{"issue":"9682","key":"10.1002\/14651858.CD012557.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0140-6736(09)60746-7","article-title":"Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders","volume":"373","author":"Rehm","year":"2009","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD012557.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/alcalc\/agt127","article-title":"Defining substance use disorders: do we really need more than heavy use?","volume":"48","author":"Rehm","year":"2013","journal-title":"Alcohol and Alcoholism"},{"issue":"9","key":"10.1002\/14651858.CD012557.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/add.12231","article-title":"Alcohol use disorders and mortality: a systematic review and meta-analysis","volume":"108","author":"Roerecke","year":"2013","journal-title":"Addiction"},{"issue":"2","key":"10.1002\/14651858.CD012557.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/JCP.0b013e3182860e84","article-title":"Baclofen for alcohol-dependence: anticraving or partial substitution?","volume":"33","author":"Rolland","year":"2013","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD012557.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/add.14191","article-title":"Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta-analysis","volume":"113","author":"Rose","year":"2018","journal-title":"Addiction"},{"issue":"9","key":"10.1002\/14651858.CD012557.pub2-BIB0094|cit94","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004332.pub2","article-title":"Acamprosate for alcohol dependence","author":"R\u00f6sner","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD012557.pub2-BIB0095|cit95","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001867.pub3","article-title":"Opioid antagonists for alcohol dependence","author":"R\u00f6sner","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD012557.pub2-BIB0096|cit96","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008358.pub2","article-title":"Magnesium for alcohol withdrawal","author":"Sarai","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0097|cit97","unstructured":"Schwarz Pharma Kemstro\u00ae (oral baclofen tablets) package insert Schwarz Pharma, Monheim, Germany 2003"},{"issue":"5","key":"10.1002\/14651858.CD012557.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1164\/rccm.200602-197ST","article-title":"An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations","volume":"174","author":"Sch\u00fcnemann","year":"2006","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012557.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000115677","article-title":"Efficacy of baclofen in trigeminal neuralgia and some other painful conditions. A clinical trial","volume":"23","author":"Steardo","year":"1984","journal-title":"European Neurology"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0100|cit100","unstructured":"Sterne JAC Egger M Moher D Boutron I (editors) Chapter 10: Addressing reporting biases. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017 Available fromwww.training.cochrane.org\/handbook"},{"issue":"11","key":"10.1002\/14651858.CD012557.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.euroneuro.2017.08.434","article-title":"Systematic review: baclofen dosing protocols for alcohol use disorders used in observational studies","volume":"27","author":"Thompson","year":"2017","journal-title":"European Neuropsychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD012557.pub2-BIB0102|cit102","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003352.pub4","article-title":"Dopaminergic antagonists for alcohol dependence","author":"Vaz de Lima","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"37","key":"10.1002\/14651858.CD012557.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"15037","DOI":"10.1073\/pnas.1010654108","article-title":"Addiction: beyond dopamine reward circuitry","volume":"108","author":"Volkow","journal-title":"Proceedings of the National Academy of Sciences USA"},{"issue":"1","key":"10.1002\/14651858.CD012557.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1530-0277.2006.00259.x","article-title":"The gamma-aminobutyric acid-B receptor agonist baclofen attenuates responding for ethanol in ethanol-dependent rats","volume":"31","author":"Walker","year":"2007","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"9","key":"10.1002\/14651858.CD012557.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1111\/acer.12815","article-title":"Converging patterns of alcohol use and related outcomes among females and males in the United States, 2002 to 2012","volume":"39","author":"White","year":"2015","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0106|cit106","volume-title":"International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10)","author":"World Health Organization","year":"1992"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0107|cit107","article-title":"The world health report 2002 - Reducing risks to health, promoting healthy life. Geneva: WHO2002.","volume-title":"The World Health Report 2002 - reducing risks, promoting healthy life","author":"World Health Organization","year":"2002"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0108|cit108","volume-title":"Alcohol in developing societies: a public health approach","author":"World Health Organization","year":"2002"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0109|cit109","volume-title":"International Statistical Classification of Diseases and Related Health Problems","author":"World Health Organization","year":"2010"},{"key":"10.1002\/14651858.CD012557.pub2-BIB0110|cit110","volume-title":"Global status report on alcohol and health","author":"World Health Organization","year":"2014"},{"issue":"1","key":"10.1002\/14651858.CD012557.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/can.2016.0016","article-title":"Maintenance of blinding in clinical trials and the implications for studying analgesia using cannabinoids","volume":"1","author":"Wilsey","year":"2016","journal-title":"Cannabis and Cannabinoid Research"},{"issue":"10","key":"10.1002\/14651858.CD012557.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.tins.2009.06.004","article-title":"Roles for nigrostriatal--not just mesocorticolimbic--dopamine in reward and addiction","volume":"32","author":"Wise","year":"2009","journal-title":"Trends in Neurosciences"},{"issue":"14","key":"10.1002\/14651858.CD012557.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1523\/JNEUROSCI.4977-13.2014","article-title":"Nipping cue reactivity in the bud: baclofen prevents limbic activation elicited by subliminal drug cues","volume":"34","author":"Young","year":"2014","journal-title":"Journal of Neuroscience"}],"updated-by":[{"DOI":"10.1002\/14651858.cd012557.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012557.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T23:08:14Z","timestamp":1628550494000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD012557.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Drugs and Alcohol Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,11,26]]},"references-count":113,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012557.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD012557.pub3","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,26]]}}}